TG Therapeutics | TGTX - Passivo Circulante





Passivo Circulante Alterar Data
AbbVie USD 42.1B 1.19B 2026-03
Alaunos Therapeutics USD 595K 218K 2026-03
Amgen USD 24.96B 534M 2026-03
Ardelyx USD 109.57M 20.96M 2026-03
Arrowhead Research USD 295.22M 52.2M 2026-03
Bayer EUR 33.46B 875M 2026-03
Biogen USD 3B 350.5M 2026-03
Corcept Therapeutics USD 149.18M 16.9M 2026-03
Curis USD 14.08M 5.3M 2025-12
Gilead Sciences USD 9.48B 2.34B 2026-03
J&J USD 57.72B 3.59B 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
Novartis USD 31.37B 4.1B 2026-03
Novavax USD 342.46M 117.49M 2026-03
PTC Therapeutics USD 923.6M 44.82M 2026-03
Puma Biotechnology USD 82.73M 3.63M 2025-09
Regeneron Pharmaceuticals USD 5.11B 739.3M 2026-03
Roche Holding CHF 28B 421M 2025-12
TG Therapeutics USD 187.11M 33.35M 2026-03
Verastem USD 72.27M 12.56M 2025-12
Vertex Pharmaceuticals USD 3.88B 19.4M 2026-03